Skip to main content

Advertisement

SpringerLink
Log in

Genomic Binding Sites and Biological Effects of the Vitamin D: VDR Complex in Multiple Sclerosis

  • Review Paper
  • Published:
NeuroMolecular Medicine Aims and scope Submit manuscript

An Erratum to this article was published on 10 May 2014

Abstract

Environmental factors greatly contribute to the development of complex trait disorders. With the rapid developments in the fields of biotechnology and informatics, the investigations of molecular interactions between host and environmental factors became very detailed and comprehensive. The effects of ultraviolet irradiation, vitamin D synthesis, and receptor binding, and then the involvements of the ligand–receptor complexes in the regulation of cell function received much attention in the last few years and paralleled the accumulation of information concerning genetic determinants of disease susceptibility, transcriptional regulation, cell cycle, mitochondrial biochemistry, and many other elements of cell biology. The importance of vitamin D in contributing to immune regulation, autoimmunity, and susceptibility to multiple sclerosis (MS) is now also recognized, and there are ongoing treatment trials with vitamin D to define whether it is capable of modifying susceptibility to or the course of the disease. This survey aims to capture that part of vitamin D research that helps to better understand the interactions of this molecule and its receptor with the human genome, and the downstream effects of these interactions relevant to immune homeostasis and MS. This relatively narrow scope reveals a very complex molecular network underlying inflammatory demyelination and allows us to hope that a better understanding of the roles of vitamin D and other environmental factors will once make the risk of MS modifiable or, to some degrees, the disease preventable.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Achiron, A., Feldman, A., & Gurevich, M. (2011). Characterization of multiple sclerosis traits: Nuclear receptors (NR) impaired apoptosis pathway and the role of 1-α 25-dihydroxyvitamin D3. Journal of the Neurological Sciences, 311(1–2), 9–14.

    Article  CAS  PubMed  Google Scholar 

  • Adorini, L., & Penna, G. (2009). Induction of tolerogenic dendritic cells by vitamin D receptor agonists. Handbook of Experimental Pharmacology, 188, 251–273.

    Article  CAS  PubMed  Google Scholar 

  • Adzemovic, M. Z., Zeitelhofer, M., Hochmeister, S., Gustafsson, S. A., & Jagodic, M. (2013). Efficacy of vitamin D in treating multiple sclerosis-like neuroinflammation depends on developmental stage. Experimental Neurology, 249, 39–48.

    Article  CAS  PubMed  Google Scholar 

  • Alroy, I., Towers, T. L., & Freedman, L. P. (1995). Transcriptional repression of the interleukin-2 gene by vitamin D3: Direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Molecular and Cellular Biology, 15(10), 5789–5799.

    CAS  PubMed Central  PubMed  Google Scholar 

  • An, B. S., Tavera-Mendoza, L. E., Dimitrov, V., Wang, X., Calderon, M. R., Wang, H. J., et al. (2010). Stimulation of Sirt1-regulated FoxO protein function by the ligand-bound vitamin D receptor. Molecular and Cellular Biology, 30(20), 4890–4900.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Ascherio, A., & Munger, K. L. (2010). Epstein-barr virus infection and multiple sclerosis: A review. J Neuroimmune Pharmacol., 5(3), 271–277.

    Article  PubMed  Google Scholar 

  • Ascherio, A., Munger, K. L., & Simon, K. C. (2010). Vitamin D and multiple sclerosis: Review. The Lancet Neurology, 9(6), 599–612.

    Article  Google Scholar 

  • Aslam, F., McCabe, L., Frenkel, B., van Wijnen, A. J., Stein, G. S., Lian, J. B., et al. (1999). AP-1 and vitamin D receptor (VDR) signaling pathways converge at the rat osteocalcin VDR element: Requirement for the internal activating protein-1 site for vitamin D-mediated trans-activation. Endocrinology, 140(1), 63–70.

    CAS  PubMed  Google Scholar 

  • Baranzini, S. E. (2011). Revealing the genetic basis of multiple sclerosis: Are we there yet? Current Opinion in Genetics & Development, 21(3), 317–324.

    Article  CAS  Google Scholar 

  • Baranzini, S. E., Galwey, N. W., Wang, J., Khankhanian, P., Lindberg, R., Pelletier, D., Wu, W., Uitdehaag, B. M., Kappos, L., GeneMSA Consortium, Polman, C. H., Matthews, P. M., Hauser, S. L., Gibson, R. A., Oksenberg, J. R., Barnes, M. R. (2009). Pathway and network-based analysis of genome-wide association studies in multiple sclerosis. Human Molecular Genetics, 18(11), 2078–2090.

    Google Scholar 

  • Barreyro, F. J., Kobayashi, S., Bronk, S. F., Werneburg, N. W., Malhi, H., & Gores, G. J. (2007). Transcriptional regulation of Bim by FoxO3A mediates hepatocyte lipoapoptosis. Journal of Biological Chemistry, 282(37), 27141–27154.

    Article  CAS  PubMed  Google Scholar 

  • Bernstein, B. E., Birney, E., Dunham, I., Green, E. D., Gunter, C., & Snyder, M. (2012). ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature, 489(7414), 57–74.

    Article  PubMed  Google Scholar 

  • Brennan, A., Katz, D. R., Nunn, J. D., Barker, S., Hewison, M., Fraher, L. J., et al. (1987). Dendritic cells from human tissues express receptors for the immunoregulatory vitamin D3 metabolite, dihydroxycholecalciferol. Immunology, 61(4), 457–461.

    CAS  PubMed Central  PubMed  Google Scholar 

  • Bruce, D., & Cantorna, M. T. (2011). Intrinsic requirement for the vitamin D receptor in the development of CD8αα-expressing T cells. J Immunol., 186(5), 2819–2825.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Cantorna, M. T., Hayes, C. E., & DeLuca, H. F. (1996). 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America, 93(15), 7861–7864.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Cantorna, M. T., Zhao, J., & Yang, L. (2012). Vitamin D, invariant natural killer T-cells and experimental autoimmune disease. The Proceedings of the Nutrition Society, 71(1), 62–66.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Chang, J. H., Cha, H. R., Lee, D. S., Seo, K. Y., & Kweon, M. N. (2010). 1,25-Dihydroxyvitamin D3 inhibits the differentiation and migration of T(H)17 cells to protect against experimental autoimmune encephalomyelitis. PLoS ONE, 5(9), e12925.

    Article  PubMed Central  PubMed  Google Scholar 

  • Chen, S., Sims, G. P., Chen, X. X., Gu, Y. Y., & Lipsky, P. E. (2007). Modulatory effects of 1,3-dihydroxyvitamin D3 on human B cell differentiation. Journal of Immunology, 179, 1634–1647.

    Article  CAS  Google Scholar 

  • Compston, A. (1999). The genetic epidemiology of multiple sclerosis. Philosophical Transactions of the Royal Society of London. Series B, Biological sciences, 354(1390), 1623–1634.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Daitoku, H., Hatta, M., Matsuzaki, H., Aratani, S., Ohshima, T., Miyagishi, M., et al. (2004). Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity. Proceedings of the National Academy of Sciences of the United States of America, 101(27), 10042–10047.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Deluca, H. F., & Cantorna, M. T. (2001). Vitamin D: Its role and uses in immunology. FASEB Journal, 15(14), 2579–2585.

    Article  CAS  PubMed  Google Scholar 

  • Dimitrov, V., Salehi-Tabar, R., An, B. S., & White, J. H. (2013). Non-classical mechanisms of transcriptional regulation by the vitamin D receptor: Insights into calcium homeostasis, immune system regulation and cancer chemoprevention. The Journal of Steroid Biochemistry and Molecular Biology. doi:10.1016/j.jsbmb.2013.07.012.

  • Disanto, G., Morahan, J. M., Barnett, M. H., Giovannoni, G., & Ramagopalan, S. V. (2012a). The evidence for a role of B cells in multiple sclerosis. Neurology, 78(11), 823–832.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Disanto, G., Sandve, G. K., Berlanga-Taylor, A. J., Morahan, J. M., Dobson, R., Giovannoni, G., et al. (2012b). Genomic regions associated with multiple sclerosis are active in B cells. PLoS ONE, 7(3), e32281. doi:10.1371/journal.pone.0032281.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Disanto, G., Sandve, G. K., Berlanga-Taylor, A. J., Ragnedda, G., Morahan, J. M., Watson, C. T., et al. (2012c). Vitamin D receptor binding, chromatin states and association with multiple sclerosis. Human Molecular Genetics, 21(16), 3575–3586.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Dörr, J., Döring, A., & Paul, F. (2013). Can we prevent or treat multiple sclerosis by individualised vitamin D supply? EPMA Journal, 4(1), 4. doi:10.0086/1878-5085-4-4.

    Article  PubMed Central  PubMed  Google Scholar 

  • Dörr, J., Ohlraun, S., Skarabis, H., & Paul, F. (2012). Efficacy of vitamin D supplementation in multiple sclerosis (EVIDIMS Trial): Study protocol for a randomized controlled trial. Trials, 13, 15.

    Article  PubMed Central  PubMed  Google Scholar 

  • Ernst, J., Kheradpour, P., Mikkelsen, T. S., Shoresh, N., Ward, L. D., Epstein, C. B., et al. (2011). Mapping and analysis of chromatin state dynamics in nine human cell types. Nature, 473(7345), 43–49.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Eyles, D., Almeras, L., Benech, P., Patatian, A., Mackay-Sim, A., McGrath, J., et al. (2007). Developmental vitamin D deficiency alters the expression of genes encoding mitochondrial, cytoskeletal and synaptic proteins in the adult rat brain. Journal of Steroid Biochemistry and Molecular Biology, 103(3–5), 538–545.

    Article  CAS  PubMed  Google Scholar 

  • Garcia-Martin, E., Agundez, J. A., Martinez, C., Benito-Leon, J., Millan-Pacual, J., Calleja, P., et al. (2013). Vitamin D3 receptor (VDR) gene rs2228570 (Fok1) and rs731236 (Taq1) variants are not associated with the risk for multiple sclerosis: Results of a new study and a meta-analysis. PLoS ONE, 8(6), e65487. doi:10.1371/journal.pone.0065487.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Grishkan, I. V., Fairchild, A. N., Calabresi, P. A., & Gocke, A. R. (2013). 1,25-Dihydroxyvitamin D3 selectively and reversibly impairs T helper-cell CNS localization. Proceedings of the National Academy of Sciences of the United States of America, 110(52), 21101–21106.

    Article  CAS  PubMed  Google Scholar 

  • Hafler, D. A., Compston, A., Sawcer, S., Lander, E. S., Daly, M. J., De Jager, P. L., et al. (2007). Risk alleles for multiple sclerosis identified by a genomewide study. New England Journal of Medicine, 357, 851–862.

    Article  CAS  PubMed  Google Scholar 

  • Handel, A. E., Sandve, G. K., Disanto, G., Berlanga-Taylor, A. J., Gallone, G., Hanwell, H., et al. (2013). Vitamin D receptor ChIP-seq in primary CD4+ cells: Relationship to serum 25-hydroxyvitamin D levels and autoimmune disease. BMC Medicine, 11, 163. doi:10.1186/1741-7015-11-163.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Handunnetthi, L., Ramagopalan, S. V., & Ebers, G. C. (2010). Multiple sclerosis, vitamin D, and HLA-DRB1*15. Neurolog., 74(23), 1905–1910. doi:10.1212/WNL.0b013e3181e24124.

    Article  CAS  Google Scholar 

  • Heikkinen, S., Väisänen, S., Pehkonen, P., Seuter, S., Benes, V., & Carlberg, C. (2011). Nuclear hormone 1α,25-dihydroxyvitamin D3 elicits a genome-wide shift in the locations of VDR chromatin occupancy. Nucleic Acids Research, 39(21), 9181–9193.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • James, E., Dobson, R., Kuhle, J., Baker, D., Giovannoni, G., & Ramagopalan, S. V. (2013). The effect of vitamin D-related interventions on multiple sclerosis relapses: A meta-analysis. Multiple Sclerosis, 19(12), 1571–1579.

    Google Scholar 

  • Joshi, S., Pantalena, L. C., Liu, X. K., Gaffen, S. L., Liu, H., Rohowsky-Kochan, C., et al. (2011). 1,25-dihydroxyvitamin D(3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A. Molecular and Cellular Biology, 31(17), 3653–3669.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Kim, M. S., Fujiki, R., Murayama, A., Kitagawa, H., Yamaoka, K., Yamamoto, Y., et al. (2007). 1Alpha,25(OH)2D3-induced transrepression by vitamin D receptor through E-box-type elements in the human parathyroid hormone gene promoter. Molecular Endocrinology, 21(2), 334–342.

    Article  CAS  PubMed  Google Scholar 

  • Kim, S. Y., Herbst, A., Tworkowski, K. A., Salghetti, S. E., & Tansey, W. P. (2003). Skp2 regulates Myc protein stability and activity. Molecular Cell, 11(5), 1177–1188.

    Article  CAS  PubMed  Google Scholar 

  • Knippenberg, S., Smolders, J., Thewissen, M., Peelen, E., Tervaert, J. W., Hupperts, R., et al. (2011). Effect of vitamin D(3) supplementation on peripheral B cell differentiation and isotype switching in patients with multiple sclerosis. Multiple Sclerosis, 17(12), 1418–1423.

    Article  CAS  PubMed  Google Scholar 

  • Kongsbak, M., Levring, T. B., Geisler, C., & von Essen, M. R. (2013). The vitamin d receptor and T cell function. Frontiers in Immunology, 4, 148. doi:10.3389/fimmu.2013.00148.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Li, B., Baylink, D. J., Deb, C., Zannetti, C., Rajaallah, F., Xing, W., et al. (2013a). 1,25-Dihydroxyvitamin D3 suppresses TLR8 expression and TLR8-mediated inflammatory responses in monocytes in vitro and experimental autoimmune encephalomyelitis in vivo. PLoS ONE, 8(3), e58808. doi:10.1371/journal.pone.0058808.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Li, Y. C., Chen, Y., Liu, W., & Thadhani, R. (2013b). MicroRNA-mediated mechanism of vitamin D regulation of innate immune response. The Journal of Steroid Biochemistry and Molecular Biology. doi: 10.1016/j.jsbmb.2013.09.014.

  • Lin, R., Wang, T. T., Miller, W. H, Jr, & White, J. H. (2003). Inhibition of F-Box protein p45(SKP2) expression and stabilization of cyclin-dependent kinase inhibitor p27(KIP1) in vitamin D analog-treated cancer cells. Endocrinology, 144(3), 749–753.

    Article  CAS  PubMed  Google Scholar 

  • Mayne, C. G., Spanier, J. A., Relland, L. M., Williams, C. B., & Hayes, C. E. (2011). 1,25-Dihydroxyvitamin D3 acts directly on the T lymphocyte vitamin D receptor to inhibit experimental autoimmune encephalomyelitis. European Journal of Immunology, 41(3), 822–832.

    Article  CAS  PubMed  Google Scholar 

  • Meyer, M. B., Benkusky, N. A., & Pike, J. W. (2013). 1,25-Dihydroxyvitamin D3 induced histone profiles guide discovery of VDR action sites. The Journal of Steroid Biochemistry and Molecular Biology. doi:10.1016/j.jsbmb.2013.09.005.

  • Morán-Auth, Y., Penna-Martinez, M., Shoghi, F., Ramos-Lopez, E., & Badenhoop, K. (2013). Vitamin D status and gene transcription in immune cells. Journal of Steroid Biochemistry and Molecular Biology, 136, 83–85. doi:10.1016/j.jsbmb.2013.02.005.

    Article  PubMed  Google Scholar 

  • Morin, P. J. (1999). Beta-catenin signaling and cancer. BioEssays, 21(12), 1021–1030.

    Article  CAS  PubMed  Google Scholar 

  • Murayama, A., Kim, M. S., Yanagisawa, J., Takeyama, K., & Kato, S. (2004). Transrepression by a liganded nuclear receptor via a bHLH activator through co-regulator switching. EMBO Journal, 23(7), 1598–1608.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Nashold, F. E., Miller, D. J., & Hayes, C. E. (2000). 1,25-dihydroxyvitamin D3 treatment decreases macrophage accumulation in the CNS of mice with experimental autoimmune encephalomyelitis. Journal of Neuroimmunology, 103(2), 171–179.

    Article  CAS  PubMed  Google Scholar 

  • Nashold, F. E., Nelson, C. D., Brown, L. M., & Hayes, C. E. (2013). One calcitriol dose transiently increases Helios+ FoxP3+ T cells and ameliorates autoimmune demyelinating disease. Journal of Neuroimmunology, 263(1–2), 64–74.

    Article  CAS  PubMed  Google Scholar 

  • Palmer, H. G., González-Sancho, J. M., Espada, J., Berciano, M. T., Puig, I., Baulida, J., et al. (2001). Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. Journal of Cell Biology, 154(2), 369–387.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Ramagopalan, S. V., Dyment, D. A., Cader, M. Z., Morrison, K. M., Disanto, G., Morahan, J. M., et al. (2011). Rare variants in the CYP27B1 gene are associated with multiple sclerosis. Annals of Neurology, 70(6), 881–886.

    Article  CAS  PubMed  Google Scholar 

  • Ramagopalan, S. V., Heger, A., Berlanga, A. J., Maugeri, N. J., Lincoln, M. R., Burrell, A., et al. (2010). A ChIP-seq defined genome-wide map of vitamin D receptor binding: Associations with disease and evolution. Genome Research, 20(10), 1352–1360.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Ramagopalan, S. V., Lee, J. D., Yee, I. M., Guimond, C., Traboulsee, A. L., Ebers, G. C., et al. (2013). Association of smoking with risk of multiple sclerosis: A population-based study. Journal of Neurology, 260(7), 1778–1781.

    Article  PubMed  Google Scholar 

  • Ramagopalan, S. V., Maugeri, N. J., Handunnetthi, L., Lincoln, M. R., Orton, S. M., Dyment, D. A., et al. (2009). Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genetics, 5(2), e1000369. doi:10.1371/journal.pgen.1000369.

    Article  PubMed Central  PubMed  Google Scholar 

  • Salehi-Tabar, R., Nguyen-Yamamoto, L., Tavera-Mendoza, L. E., Quail, T., Dimitrov, V., An, B. S., et al. (2012). Vitamin D receptor as a master regulator of the c-MYC/MXD1 network. Proceedings of the National Academy of Sciences of the United States of America, 109(46), 18827–18832.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Salzer, J., & Sundström, P. (2013). Timing of cigarette smoking as a risk factor for multiple sclerosis. Therapeutic Advances in Neurological Disorders, 6(3), 205.

    Article  PubMed Central  PubMed  Google Scholar 

  • Sanseverino, I., Rinaldi, A. O., Purificato, C., Cortese, A., Millefiorini, E., Gessani, S., & Gauzzi, M. C. (2013). CCL2 induction by 1,25(OH)2D3 in dendritic cells from healthy donors and multiple sclerosis patients. The Journal of Steroid Biochemistry and Molecular Biology. doi:10.1016/j.jsbmb.2013.10.018.

  • Satoh, J., & Tabunoki, H. (2013). Molecular network of chromatin immunoprecipitation followed by deep sequencing-based vitamin D receptor target genes. Multiple Sclerosis, 19(8), 1035–1045.

    Article  PubMed  Google Scholar 

  • Schmidt, M., Fernandez de Mattos, S., van der Horst, A., Klompmaker, R., Kops, G. J., Lam, E. W., et al. (2002). Cell cycle inhibition by FoxO forkhead transcription factors involves downregulation of cyclin D. Molecular and Cellular Biology, 22(22), 7842–7852.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Seuter, S., Heikkinen, S., & Carlberg, C. (2013). Chromatin acetylation at transcription start sites and vitamin D receptor binding regions relates to effects of 1α,25-dihydroxyvitamin D3 and histone deacetylase inhibitors on gene expression. Nucleic Acids Research, 41(1), 110–124.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Shah, S., Hecht, A., Pestell, R., & Byers, S. W. (2003). Trans-repression of beta-catenin activity by nuclear receptors. Journal of Biological Chemistry, 278(48), 48137–48145.

    Article  CAS  PubMed  Google Scholar 

  • Shah, S., Islam, M. N., Dakshanamurthy, S., Rizvi, I., Rao, M., Herrell, R., et al. (2006). The molecular basis of vitamin D receptor and beta-catenin crossregulation. Molecular Cell, 21(6), 799–809.

    Article  PubMed  Google Scholar 

  • Simon, K. C., Munger, K. L., & Ascherio, A. (2012). Vitamin D and multiple sclerosis: Epidemiology, immunology, and genetics. Current Opinion in Neurology, 25(3), 246–251.

    Article  CAS  PubMed  Google Scholar 

  • Simon, K. C., Munger, K. L., Yang, Xing, & Ascherio, A. (2010a). Polymorphisms in vitamin D metabolism related genes and risk of multiple sclerosis. Multiple Sclerosis, 16(2), 133–138.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Simon, K. C., van der Mei, I. A., Munger, K. L., Ponsonby, A., Dickinson, J., Dwyer, T., et al. (2010b). Combined effects of smoking, anti-EBNA antibodies, and HLA-DRB1*1501 on multiple sclerosis risk. Neurology., 74(17), 1365–1371.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Sloka, S., Silva, C., Wang, J., & Yong, V. W. (2011). Predominance of Th2 polarization by vitamin D through a STAT6-dependent mechanism. J Neuroinflammation., 8, 56. doi:10.1186/1742-2094-8-56.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Smolders, J., & Damoiseaux, J. (2011). Vitamin D as a T-cell modulator in multiple sclerosis. Vitamins and Hormones, 86, 401–428.

    Article  CAS  PubMed  Google Scholar 

  • Smolders, J., Damoiseaux, J., Menheere, P., Tervaert, J. W., & Hupperts, R. (2009). Association study on two vitamin D receptor gene polymorphisms and vitamin D metabolites in multiple sclerosis. Annals of the New York Academy of Sciences, 1173, 515–520. doi:10.1111/j.1749-6632.2009.04656.x.

    Article  CAS  PubMed  Google Scholar 

  • Smolders, J., Hupperts, R., Barkhof, F., Grimaldi, L. M., Holmoy, T., Killestein, J., et al. (2011). Efficacy of vitamin D3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: A Phase II, multicenter, double-blind, randomized, placebo-controlled trial. Journal of the Neurological Sciences, 311(1–2), 44–49.

    Article  CAS  PubMed  Google Scholar 

  • Smolders, J., Peelen, E., Thewissen, M., Menheere, P., Damoiseaux, J., & Hupperts, R. (2014). Circulating vitamin D binding protein levels are not associated with relapses or with vitamin D status in multiple sclerosis. Multiple Sclerosis, 20(4), 433–437.

    Google Scholar 

  • Smolders, J., Schuurman, K. G., van Strien, M. E., Melief, J., Hendrickx, D., Hol, E. M., et al. (2013). Expression of vitamin D receptor and metabolizing enzymes in multiple sclerosis-affected brain tissue. Journal of Neuropathology and Experimental Neurology, 72(2), 91–105.

    Google Scholar 

  • Spach, K. M., Pedersen, L. B., Nashold, F. E., Kayo, T., Yandell, B. S., Prolla, T. A., et al. (2004). Gene expression analysis suggests that 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by stimulating inflammatory cell apoptosis. Physiological Genomics, 18(2), 141–151.

    Article  CAS  PubMed  Google Scholar 

  • Spanier, J. A., Nashold, F. E., Olson, J. K., & Hayes, C. E. (2012). The Ifng gene is essential for Vdr gene expression and vitamin D3-mediated reduction of the pathogenic T cell burden in the central nervous system in experimental autoimmune encephalomyelitis, a multiple sclerosis model. Journal of Immunology, 189(6), 3188–3197.

    Article  CAS  Google Scholar 

  • Tajouri, L., Ovcaric, M., Curtain, R., Johnson, M. P., Griffiths, L. R., Csurhes, P., et al. (2005). Variation in the vitamin D receptor gene is associated with multiple sclerosis in an Australian population. Journal of Neurogenetics, 19(1), 25–38.

    Article  CAS  PubMed  Google Scholar 

  • The International Multiple Sclerosis Consortium. (2013b). Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nature Genetics, 45(11), 1353–1360.

    Google Scholar 

  • The International Multiple Sclerosis Consortium and the Wellcome Trust Case Control Consortium 2. (2011). Genetic risk and a primary role for cell-mediated immune mechanism in multiple sclerosis. Nature, 476, 214–218.

    Google Scholar 

  • The International Multiple Sclerosis Genetics Consortium. (2013a). Network-based multiple sclerosis pathway analysis with GWAS data from 15,000 cases and 30,000 controls. American Journal of Human Genetics, 92, 1–12.

    Google Scholar 

  • Towers, T. L., & Freedman, L. P. (1998). Granulocyte-macrophage colony-stimulating factor gene transcription is directly repressed by the vitamin D3 receptor. Implications for allosteric influences on nuclear receptor structure and function by a DNA element. Journal of Biological Chemistry, 273(17), 10338–10348.

    Article  CAS  PubMed  Google Scholar 

  • Tuller, T., Atar, S., Ruppin, E., Gurevich, M., & Achiron, A. (2013). Common and specific signatures of gene expression and protein–protein interactions in autoimmune diseases. Genes and Immunity, 14(2), 67–82.

    Article  CAS  PubMed  Google Scholar 

  • van Etten, E., & Mathieu, C. (2005). Immunoregulation by 1,25-dihydroxyvitamin D3: Basic concepts. The Journal of Steroid Biochemistry and Molecular Biology, 97(1–2), 93–101.

    Article  PubMed  Google Scholar 

  • Verstuyf, A., Carmeliet, G., Bouillon, R., & Mathieu, C. (2010). Vitamin D: A pleiotropic hormone. Kidney International, 78, 140–145.

    Article  CAS  PubMed  Google Scholar 

  • Verway, M., Bouttier, M., Wang, T. T., Calderon, M., An, B. S., Devemy, E., Mcintosh, F., Divangahi, M., Behr, M. A., & White, J. H. (2013). Vitamin D induces interleukin-1β expression: Paracrine macrophage epithelial signaling controls M. tuberculosis infection. PLOS Pathogens. doi:10.1371/journal.ppat.1003407.

  • Virtanen, J. O., & Jacobson, S. (2012). Viruses and multiple sclerosis. CNS & Neurological Disorders: Drug Targets, 11(5), 528–544.

    Article  CAS  Google Scholar 

  • von der Lehr, N., Johansson, S., Wu, S., Bahram, F., Castell, A., Cetinkaya, C., et al. (2003). The F-box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor for c-Myc-regulated transcription. Molecular Cell, 11(5), 1189–1200.

    Article  PubMed  Google Scholar 

  • von Essen, M. R., Kongsbak, M., Schjerling, P., Olgaard, K., Odum, N., & Geisler, C. (2010). Vitamin D controls T cell antigen receptor signaling and activation of human T cells. Nature Immunology, 11(4), 344–349.

    Article  Google Scholar 

  • Willer, C. J., Dyment, D. A., Risch, N. J., Sadovnick, A. D., & Ebers, G. C. (2003). Twin concordance and sibling recurrence rates in multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America, 100(22), 12877–12882.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Yu, S., Bruce, D., Froicu, M., Weaver, V., & Cantorna, M. T. (2008). Failure of T cell homing, reduced CD4/CD8alphaalpha intraepithelial lymphocytes, and inflammation in the gut of vitamin D receptor KO mice. Proceedings of the National Academy of Sciences of the United States of America, 105(52), 20834–20839.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Zittermann, A., Tenderich, G., & Koerfer, R. (2009). Vitamin D and the adaptive immune system with special emphasis to allergic reactions and allograft rejection. Inflammation & Allergy: Drug Targets, 8(2), 161–168.

    Article  CAS  Google Scholar 

Download references

Acknowledgments

The authors are supported by the Markusovszky University Teaching Hospital and the University of Pecs, Faculty of the Health Sciences.

Conflict of interest

The authors declare that they have no conflict of interests.

Author information

Authors and Affiliations

  1. Faculty of Health Sciences, University of Pecs, Center for Research and Education, Markusovszky University Teaching Hospital, Markusovszky Street 5, 9700, Szombathely, Hungary

    Bernadette Kalman & Erzsebet Toldy

Authors
  1. Bernadette Kalman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Erzsebet Toldy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bernadette Kalman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kalman, B., Toldy, E. Genomic Binding Sites and Biological Effects of the Vitamin D: VDR Complex in Multiple Sclerosis. Neuromol Med 16, 265–279 (2014). https://doi.org/10.1007/s12017-014-8301-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12017-014-8301-2

Keywords

Search

Navigation